Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny C Hsu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|January 7, 2012
Multiple myelomaDanny C Hsu, Peter Wilkenfeld, Douglas E Joshua
Journal of the American Chemical Society|November 20, 2009
Complete mapping of the stereochemical course of retentive deprotonation/alkylation of 1H-benzo[e][1,4]diazepin-2(3H)-onesDanny C Hsu, Polo C-H Lam, Carla Slebodnick, et al.
The Journal of Organic Chemistry|September 11, 2010
Axial-selective H/D exchange of glycine-derived 1H-benzo[e][1,4]diazepin-2(3H)-ones: kinetic and computational studies of enantiomerizationPaul R Carlier, Yang-Sheng Sun, Danny C Hsu, et al.
Journal of the American Chemical Society|November 23, 2006
Enantioselective synthesis of diversely substituted quaternary 1,4-benzodiazepin-2-ones and 1,4-benzodiazepine-2,5-dionesPaul R Carlier, Hongwu Zhao, Stephanie L MacQuarrie-Hunter, et al.
Journal of Medicinal Chemistry|August 28, 2009
Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3Quinn P Peterson, Danny C Hsu, David R Goode, et al.
ACS Combinatorial Science|October 20, 2011
Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1)Danny C Hsu, Howard S Roth, Diana C West, et al.
Cost Effectiveness and Resource Allocation : C/E|November 21, 2021
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong KongTak Hong Cheung, Sally Shuk Yee Cheng, Danny C Hsu, et al.
Cancer Research|September 9, 2010
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compoundQuinn P Peterson, Danny C Hsu, Chris J Novotny, et al.
Digestive Diseases and Sciences|May 10, 2020
Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong KongMan-Fung Yuen, Sze-Hang Liu, Wai-Kay Seto, et al.
Chemico-Biological Interactions|June 17, 2008
Towards a species-selective acetylcholinesterase inhibitor to control the mosquito vector of malaria, Anopheles gambiaePaul R Carlier, Troy D Anderson, Dawn M Wong, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|January 7, 2012
Multiple myelomaDanny C Hsu, Peter Wilkenfeld, Douglas E Joshua
Journal of the American Chemical Society|November 20, 2009
Complete mapping of the stereochemical course of retentive deprotonation/alkylation of 1H-benzo[e][1,4]diazepin-2(3H)-onesDanny C Hsu, Polo C-H Lam, Carla Slebodnick, et al.
The Journal of Organic Chemistry|September 11, 2010
Axial-selective H/D exchange of glycine-derived 1H-benzo[e][1,4]diazepin-2(3H)-ones: kinetic and computational studies of enantiomerizationPaul R Carlier, Yang-Sheng Sun, Danny C Hsu, et al.
Journal of the American Chemical Society|November 23, 2006
Enantioselective synthesis of diversely substituted quaternary 1,4-benzodiazepin-2-ones and 1,4-benzodiazepine-2,5-dionesPaul R Carlier, Hongwu Zhao, Stephanie L MacQuarrie-Hunter, et al.
Journal of Medicinal Chemistry|August 28, 2009
Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3Quinn P Peterson, Danny C Hsu, David R Goode, et al.
ACS Combinatorial Science|October 20, 2011
Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1)Danny C Hsu, Howard S Roth, Diana C West, et al.
Cost Effectiveness and Resource Allocation : C/E|November 21, 2021
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong KongTak Hong Cheung, Sally Shuk Yee Cheng, Danny C Hsu, et al.
Cancer Research|September 9, 2010
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compoundQuinn P Peterson, Danny C Hsu, Chris J Novotny, et al.
Digestive Diseases and Sciences|May 10, 2020
Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong KongMan-Fung Yuen, Sze-Hang Liu, Wai-Kay Seto, et al.
Chemico-Biological Interactions|June 17, 2008
Towards a species-selective acetylcholinesterase inhibitor to control the mosquito vector of malaria, Anopheles gambiaePaul R Carlier, Troy D Anderson, Dawn M Wong, et al.
Pageof 2